Recursion Pharmaceuticals’ (RXRX) AI Approach to Drug Discovery Shows Progress
Recursion Pharmaceuticals (RXRX) is a clinical-stage biotechnology company utilizing artificial intelligence to expedite drug ...
The Brighterside of News on MSN11h
Quantum sensing technology opens new doors in drug development
The ability to probe the smallest building blocks of matter has long fascinated scientists, fueling advancements in medicine, ...
Conduit Pharmaceuticals Inc. (CDT) Advances AI-Driven Drug Development to Phase II
We recently compiled a list of the 11 AI News and Ratings You Shouldn’t Miss. In this article, we are going to take a look at ...
Science Daily1d
DNA barcodes and citizen science images map spread of biocontrol agent for control of major invasive shrub
New research using publicly-shared DNA barcodes and citizen science images have provided new evidence on the establishment and spread of a biological control agent used for the control of the major ...
Azorobotics2d
New AI Platform Revolutionizes TB Drug Discovery by Analyzing Cell Images
A study reveals AI's role in identifying antimicrobial compounds for tuberculosis, enhancing drug development through ...
3 Top AI-Powered Biotech Stocks to Buy in February
AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...
GEN3d
Recursion Announces Promising Clinical Data on Lead AI-Based Drug Candidate for Brain Disease
Cerebral cavernous malformation (CCM) patients treated with oral drug, REC-994, showed reduction in total cerebral and brainstem lesion volume.
The Next Web4d
Will AI revolutionise drug development? Researchers say it depends on how it’s used
A high drug failure rate is more than just a pattern recognition problem. Here's how we can address some of the root causes.